Result of Annual General Meeting

RNS Number : 8875Q
Hemogenyx Pharmaceuticals PLC
30 June 2022
 

30 June 2022

 

Hemogenyx Pharmaceuticals plc  

("Hemogenyx Pharmaceuticals" or the "Company")

 

Result of Annual General Meeting

 

Hemogenyx Pharmaceuticals plc is pleased to announce that, at the Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed on a show of hands. The numbers of proxy votes for each resolution submitted prior to the meeting are presented below.

 

Proxy Voting Results

Ordinary Resolutions

Votes for

% of votes cast for

Votes Against

% of votes cast against

Total votes cast

Total votes cast as % of ISC (1)

Votes with-held (2)

1. To adopt the 2021 Annual Report and Accounts

48,304,030

99.77

110,911

0.23

48,414,941

4.94

190,357

2. To approve the Directors' Remuneration Policy

40,993,480

84.70

7,402,314

15.30

48,395,794

4.94

209,504

3. To reappoint the Company's auditor

47,905,435

98.99

490,359

1.01

48,395,794

4.94

209,504

4. To authorise the Audit Committee to determine the auditor's remuneration

47,894,585

98.93

518,814

1.07

48,413,399

4.94

191,899

5. To approve the Employee Incentive Plan with Non-Employee Sub-Plan

47,475,011

97.90

1,018,002

2.10

48,493,013

4.95

112,285

6. To authorise the Directors to allot equity securities

47,367,119

97.90

1,016,191

2.10

48,383,310

4.94

221,988

Special Resolutions

Votes for

% of votes cast for

Votes against

% of votes cast against

Total votes cast

Total votes cast as % of ISC (1)

Votes with-held (2)

7. To disapply pre-emption provisions

47,476,822

97.90

1,016,191

2.10

48,493,013

4.95

112,285

8. To reduce the notice period for general meetings

47,938,029

99.01

476,912

0.99

48,414,941

4.94

190,357

 

(1)  The Company's issued share capital (" ISC") on 28 June 2022, being the date on which members had to be entered in the register of members of the Company in order to be entitled to attend and vote at the meeting, was 979,749,321 ordinary shares.

(2)  A 'vote withheld' in respect of any resolution is not a vote in law and is not counted in the calculation of the proportion of the votes for and against it.

 

A copy of the resolutions passed has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

 

Enquiries:

 

Hemogenyx Pharmaceuticals plc

https://hemogenyx.com

Dr Vladislav Sandler, Chief Executive Officer & Co-Founder

headquarters@hemogenyx.com

Peter Redmond, Director

peter.redmond@hemogenyx.com





SP Angel Corporate Finance LLP

Tel: +44 (0)20 3470 0470

Matthew Johnson, Vadim Alexandre, Adam Cowl







Peterhouse Capital Limited

Tel: +44 (0)20 7469 0930

Lucy Williams, Duncan Vasey, Charles Goodfellow







 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBKKBBQBKDFAN
UK 100